The bladder is an important organ in the human body. It serves as a reservoir for urine, allowing us to control when and where we urinate. It also helps to regulate the pressure of our urine and keep it from becoming too concentrated. As such, any issues with the bladder can be extremely uncomfortable and even dangerous. One such issue is the presence of bladder stones, which can cause pain and difficulty in urinating. Fortunately, there is a new approach to treating bladder stones known as fulgurating. In this article, we will explore what fulgurating is and how it can be used to treat bladder stones.
Fulgurating is a minimally invasive procedure used to treat bladder stones. The procedure involves using a special device to generate an electric current which is then directed at the bladder stone. This current causes the stone to break up into smaller pieces, which are then flushed out of the bladder. The procedure is performed under general anaesthesia, and usually takes less than an hour.
Fulgurating offers several advantages over traditional bladder stone treatments. Firstly, it is a minimally invasive procedure, meaning that it requires no major surgery and is less likely to cause complications. Secondly, it is a relatively quick procedure, with most treatments taking less than an hour. Thirdly, fulgurating is a relatively safe procedure with a low risk of complications. Finally, it is a relatively affordable procedure, with most treatments costing less than traditional treatments.
Although fulgurating is a relatively safe procedure, there are some potential risks associated with it. These include the risk of infection, bleeding, damage to the bladder wall, and complications from the anaesthetic. In addition, there is a risk of the stone re-forming after the procedure. For this reason, it is important to ensure that the stone has been completely broken up before flushing it out.
Fulgurating can be used to treat bladder stones in both adults and children. However, it is important to note that the procedure is not suitable for everyone. It is generally only recommended for those with small bladder stones, as larger stones may require more invasive treatments. In addition, it is not suitable for those with certain medical conditions, such as kidney disease or a weakened immune system.
Fulgurating is a minimally invasive procedure used to treat bladder stones. It offers several advantages over traditional treatments, including being quick, safe, and relatively affordable. However, it is not suitable for everyone and there are some potential risks associated with the procedure. For this reason, it is important to consult with a doctor before undergoing fulgurating to ensure that it is the right treatment for you. Overall, fulgurating is an effective and safe way to treat bladder stones, and can provide much-needed relief from the discomfort and pain associated with them.
1.
Sub-Q Ketamine is Safe and Very Effective for Severe Depression.
2.
Study indicates that exercise can help colon cancer survivors live as long as matched individuals
3.
Contradictory Results Are Found in Two Pembrolizumab Trials for Head and Neck Cancer.
4.
Can Concurrent Boost Safely Shorten Breast Cancer Radiation?
5.
Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.
1.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
2.
Antibody-Drug Conjugates in Oncology: Breakthroughs, Clinical Updates, and Pipeline Innovation
3.
Navigating the Stages of Thyroid Cancer: A Guide for Patients
4.
Polycythemia Vera: A Historical Perspective and Contemporary Management
5.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation